The Oncosearch | Oncotarget

Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells Research Paper

Elvin Peter Chizenga, Rahul Chandran, Heidi Abrahamse

Published Jun 6, 2019

Keywords: photodynamic therapy, cervical cancer, cancer stem cells, photosensitizer, cancer resistance

Regression of BRAF^V600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases Case Report

Peter Y.M. Woo, Tai-Chung Lam, Jenny K.S. Pu, Lai-Fung Li, Roland C.Y. Leung, Jason M.K. Ho, James T.F. Zhung, Belinda Wong, Timonthy S.K. Chan, Herbert H.F. Loong, Ho-Keung Ng

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3818-3826

Keywords: glioblastoma, BRAF^V600E mutation, targeted therapies, BRAF-MEK inhibitors

Dissecting the role of RNA modification regulatory proteins in melanoma Research Paper

Parmanand Malvi, Biao Wang, Shreni Shah, Romi Gupta

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3745-3759

Keywords: RNA modifications, epitranscriptome, melanoma, MAPK, BRAF mutant melanoma

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer Research Paper

Sandeep Rajput, Zhanfang Guo, Shunqiang Li, Cynthia X. Ma

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3667-3680

Keywords: PI3K inhibitor, BKM120, eribulin, triple-negative breast cancer, patient-derived xenograft

Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential Research Paper

Balraj Singh, Vanessa N. Sarli, Hannah E. Kinne, Anna Shamsnia, Anthony Lucci

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3681-3693

Keywords: cancer evolution, metabolic adaptability in cancer, inflammatory breast cancer, minimal residual disease, TET2

Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism Priority Research Paper

Mujib Ullah, Asma Akbar, Nathan Norton Ng, Waldo Concepcion, Avnesh S. Thakor

Published May 28, 2019 · Vol. 10, No. 37 · pp. 3435-3450

Keywords: MSCs, CD9, chemoresistance, cytokine, xenograft tumors

Gene expression profiling as a potential predictor between normal and cancer samples in gastrointestinal carcinoma Research Paper

Panagiotis Apostolou, Aggelos C. Iliopoulos, Panagiotis Parsonidis, Ioannis Papasotiriou

Published May 21, 2019 · Vol. 10, No. 36 · pp. 3328-3338

Keywords: clustering analysis, gastrointestinal cancer, peripheral blood mononuclear cells, qRT-PCR

Targeting IL-6 receptor reduces IgM levels and tumor growth in Waldenström macroglobulinemia Research Paper

Weiguo Han, Stephan J. Matissek, David A. Jackson, Brandon Sklavanitis, Sherine F. Elsawa

Published May 21, 2019 · Vol. 10, No. 36 · pp. 3400-3407

Keywords: Waldenström macroglobulinemia, IL-6, Tocilizumab, tumor microenvironment

Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes Research Paper

Nicole E. James, Lindsey Beffa, Matthew T. Oliver, Ashley D. Borgstadt, Jenna B. Emerson, Clinton O. Chichester, Naohiro Yano, Richard N. Freiman, Paul A. DiSilvestro, Jennifer R. Ribeiro

Published May 21, 2019 · Vol. 10, No. 36 · pp. 3315-3327

Keywords: DUSP6, HE4, ovarian cancer, chemoresistance, ERK signaling

A bibliometric analysis of long non-coding RNA and chemotherapeutic resistance research Research Paper

Xiaoman Chen, Yulu Shi, Kaiwen Zhou, Sijie Yu, Wei Cai, Muying Ying

Published May 14, 2019 · Vol. 10, No. 35 · pp. 3267-3275

Keywords: chemotherapeutic resistance, lncRNA, citespace, bibliometric analysis

Defining molecular risk in ALK⁺ NSCLC Research Perspective

Petros Christopoulos, Jan Budczies, Martina Kirchner, Steffen Dietz, Holger SÃ¼ltmann, Michael Thomas, Albrecht Stenzinger

Published May 3, 2019 · Vol. 10, No. 33 · pp. 3093-3103

Pedf derived peptides affect colorectal cancer cell lines resistance and tumour re-growth capacity Research Paper

Paloma Honrubia-GÃ³mez, MarÃa-Pilar LÃ³pez-Garrido, Carmen Gil-Gas, JosÃ© SÃ¡nchez-SÃ¡nchez, Carmen Alvarez-Simon, Jorge Cuenca-Escalona, Ana Ferrer Perez, Enrique Arias, Raul Moreno, Francisco SÃ¡nchez-SÃ¡nchez, Carmen Ramirez-Castillejo

Published Apr 26, 2019 · Vol. 10, No. 31 · pp. 2973-2986

Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patients Research Paper

Elena Castellanos-Rizaldos, Xuan Zhang, Vasisht R. Tadigotla, Dominik G. Grimm, Chris Karlovich, Luis E. Raez, Johan K. Skog

Published Apr 23, 2019 · Vol. 10, No. 30 · pp. 2911-2920

Keywords: liquid biopsy, exosomes, ctDNA, exoNA, NSCLC

Gene expression profiling as a potential predictor between normal and cancer samples in gastrointestinal carcinoma Research Paper

Panagiotis Apostolou, Aggelos C. Iliopoulos, Panagiotis Parsonidis, Ioannis Papasotiriou

Published Apr 20, 2019

Keywords: clustering analysis, gastrointestinal cancer, peripheral blood mononuclear cells, qRT-PCR

BCR: a promiscuous fusion partner in hematopoietic disorders Review

Malalage N. Peiris, Fangda Li, Daniel J. Donoghue

Published Apr 12, 2019 · Vol. 10, No. 28 · pp. 2738-2754

Keywords: oncogenic fusion protein, chromosomal translocation, leukemia, breakpoint cluster region, RTK

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours Research Paper

Liliana D. Ordonez, Trevor Hay, Robert McEwen, Urszula M. Polanska, Adina Hughes, Oona Delpuech, Elaine Cadogan, Steve Powell, Jonathan Dry, Giusy Tornillo, Lucy Silcock, Elisabetta Leo, Mark J. O’Connor, Alan R. Clarke, Matthew J. Smalley

Published Apr 5, 2019 · Vol. 10, No. 27 · pp. 2586-2606

Keywords: PARP inhibitors, olaparib, Brca2, EMT, P-gps

A state of stochastic cancer stemness through the CDK1-SOX2 axis Research Perspective

Dinoop Ravindran Menon, Mayumi Fujita

Published Apr 5, 2019 · Vol. 10, No. 27 · pp. 2583-2585

Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach Research Paper

Zhiguang Xiao, Bianca Sperl, Silvia GÃ¤rtner, Tatiana Nedelko, Elvira Stacher-Priehse, Axel Ullrich, Pjotr G. Knyazev

Published Apr 2, 2019 · Vol. 10, No. 26 · pp. 2546-2560

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Liliana D. Ordonez, Trevor Hay, Robert McEwen, Urszula M. Polanska, Adina Hughes, Oona Delpuech, Elaine Cadogan, Steve Powell, Jonathan Dry, Giusy Tornillo, Lucy Silcock, Elisabetta Leo, Mark J. O’Connor, Alan R. Clarke, Matthew J. Smalley

Published Mar 27, 2019

Keywords: PARP inhibitors, olaparib, Brca2, EMT, P-gps

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Liliana D. Ordonez, Trevor Hay, Robert McEwen, Urszula M. Polanska, Adina Hughes, Oona Delpuech, Elaine Cadogan, Steve Powell, Jonathan Dry, Giusy Tornillo, Lucy Silcock, Elisabetta Leo, Mark J. O’Connor, Alan R. Clarke, Matthew J. Smalley

Published Mar 27, 2019

Keywords: PARP inhibitors, olaparib, Brca2, EMT, P-gps

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells Research Paper

Regression of BRAF^V600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases Case Report

Dissecting the role of RNA modification regulatory proteins in melanoma Research Paper

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer Research Paper

Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential Research Paper

Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism Priority Research Paper

Gene expression profiling as a potential predictor between normal and cancer samples in gastrointestinal carcinoma Research Paper

Targeting IL-6 receptor reduces IgM levels and tumor growth in Waldenström macroglobulinemia Research Paper

Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes Research Paper

A bibliometric analysis of long non-coding RNA and chemotherapeutic resistance research Research Paper

Defining molecular risk in ALK⁺ NSCLC Research Perspective

Pedf derived peptides affect colorectal cancer cell lines resistance and tumour re-growth capacity Research Paper

Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patients Research Paper

Gene expression profiling as a potential predictor between normal and cancer samples in gastrointestinal carcinoma Research Paper

BCR: a promiscuous fusion partner in hematopoietic disorders Review

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours Research Paper

A state of stochastic cancer stemness through the CDK1-SOX2 axis Research Perspective

Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells Research Paper

Regression of BRAFV600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases Case Report

Dissecting the role of RNA modification regulatory proteins in melanoma Research Paper

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer Research Paper

Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential Research Paper

Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism Priority Research Paper

Gene expression profiling as a potential predictor between normal and cancer samples in gastrointestinal carcinoma Research Paper

Targeting IL-6 receptor reduces IgM levels and tumor growth in Waldenström macroglobulinemia Research Paper

Inhibition of DUSP6 sensitizes ovarian cancer cells to chemotherapeutic agents via regulation of ERK signaling response genes Research Paper

A bibliometric analysis of long non-coding RNA and chemotherapeutic resistance research Research Paper

Defining molecular risk in ALK+ NSCLC Research Perspective

Pedf derived peptides affect colorectal cancer cell lines resistance and tumour re-growth capacity Research Paper

Exosome-based detection of activating and resistance EGFR mutations from plasma of non-small cell lung cancer patients Research Paper

Gene expression profiling as a potential predictor between normal and cancer samples in gastrointestinal carcinoma Research Paper

BCR: a promiscuous fusion partner in hematopoietic disorders Review

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-mutant mammary tumours Research Paper

A state of stochastic cancer stemness through the CDK1-SOX2 axis Research Perspective

Lung cancer stem cells and their aggressive progeny, controlled by EGFR/MIG6 inverse expression, dictate a novel NSCLC treatment approach Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Rapid activation of epithelial-mesenchymal transition drives PARP inhibitor resistance in Brca2-Mutant mammary tumours Research Paper

Regression of BRAF^V600E mutant adult glioblastoma after primary combined BRAF-MEK inhibitor targeted therapy: a report of two cases Case Report

Defining molecular risk in ALK⁺ NSCLC Research Perspective